NeuroBo Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
6.00
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-5.10
|
-3.50
|
1.60
|
31.37%
|
|
2022-06-30
|
-5.10
|
-0.12
|
4.98
|
97.65%
|
|
2022-03-31
|
-0.15
|
-0.17
|
-0.02
|
-13.33%
|
|
2021-12-31
|
0.00
|
-5.19
|
0.00
|
0.00%
|
|
2021-09-30
|
-5.40
|
-4.80
|
0.60
|
11.11%
|
|
2021-06-30
|
-4.50
|
-5.40
|
-0.90
|
-20.00%
|
|
2021-03-31
|
-5.70
|
-36.00
|
-30.30
|
-531.58%
|
|
2020-12-31
|
-5.70
|
-36.00
|
-30.30
|
-531.58%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-3.79
|
|
2021-12-31
|
-51.39
|
|
2020-12-31
|
-55.20
|
|
2019-12-31
|
-21.12
|
|
2018-12-31
|
-43.50
|
|
2017-12-31
|
-18.35
|
|
2016-12-31
|
-11.96
|